InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Pellini Michael J, 董事. Director active across 3 companies, notably Singular Genomics Systems, Inc.. Cumulatively, 10 reports have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €85k. History available since 26 January 2022. The latest transaction was filed on 4 March 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Pellini Michael J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
15,394 股0Common StockSEC:0001062993-25-004807:0
26,834 股Common StockSEC:0000950170-25-027099:0
31,328 股0Common StockSEC:0001062993-24-005775:0
14,775 股0Common StockSEC:0001062993-23-006337:0
4,278 股Class A Common StockSEC:0001209191-22-054001:0
60,668 股@ US$0.210812.4% 占其流量Common StockSEC:0001209191-22-034752:0
26,834 股@ US$3.3087.6% 占其流量Common StockSEC:0001209191-22-030584:0
标准退出：2022年8月16日 (T+90)
12,836 股Class A Common StockSEC:0001209191-22-028693:0
6,689 股0Common StockSEC:0001209191-22-005499:0
96,944 股Common StockSEC:0001209191-21-037021:0
10 条申报中的 10 条
About Pellini Michael J
Pellini Michael J serves as a Board Member at Singular Genomics Systems, Inc., Adaptive Biotechnologies Corp, and Sema4 Holdings Corp. In this role, he oversees operations and participates in strategic decision-making. His expertise in the biopharmaceutical sector is essential in guiding the companies towards sustainable growth.
